These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9161394)

  • 1. Stereotactic core needle biopsy and the workup of mammographic breast lesions.
    Devia A; Murray KA; Nelson EW
    Arch Surg; 1997 May; 132(5):512-5; discussion 515-7. PubMed ID: 9161394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereotactic core needle biopsy of nonpalpable breast lesions: initial experience with a promising technique.
    Seoudi H; Mortier J; Basile R; Curletti E
    Arch Surg; 1998 Apr; 133(4):366-72. PubMed ID: 9565115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excising the reexcision: stereotactic core-needle biopsy decreases need for reexcision of breast cancer.
    Kaufman CS; Delbecq R; Jacobson L
    World J Surg; 1998 Oct; 22(10):1023-7; discussion 1028. PubMed ID: 9747160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of stereotactic core needle biopsy (SCNB) of the breast at a single institution.
    Latosinsky S; Cornell D; Bear HD; Karp SE; Little S; Paredes ED
    Breast Cancer Res Treat; 2000 Apr; 60(3):277-83. PubMed ID: 10930116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic core-needle breast biopsy by surgeons: minimum 2-year follow-up of benign lesions.
    Burns RP; Brown JP; Roe SM; Sprouse LR; Yancey AE; Witherspoon LE
    Ann Surg; 2000 Oct; 232(4):542-8. PubMed ID: 10998652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uncommon high-risk lesions of the breast diagnosed at stereotactic core-needle biopsy: clinical importance.
    Philpotts LE; Shaheen NA; Jain KS; Carter D; Lee CH
    Radiology; 2000 Sep; 216(3):831-7. PubMed ID: 10966718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic core-needle biopsy of non-mass calcifications: outcome and accuracy at long-term follow-up.
    Han BK; Choe YH; Ko YH; Nam SJ; Kim JH; Yang JH
    Korean J Radiol; 2003; 4(4):217-23. PubMed ID: 14726638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial experience with the advanced breast biopsy instrumentation system.
    Matthews BD; Williams GB
    Am J Surg; 1999 Feb; 177(2):97-101. PubMed ID: 10204548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of core-needle breast biopsy on the surgical management of mammographic abnormalities.
    White RR; Halperin TJ; Olson JA; Soo MS; Bentley RC; Seigler HF
    Ann Surg; 2001 Jun; 233(6):769-77. PubMed ID: 11371735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ductal carcinoma in situ diagnosed with stereotactic core needle biopsy: can invasion be predicted?
    Lee CH; Carter D; Philpotts LE; Couce ME; Horvath LJ; Lange RC; Tocino I
    Radiology; 2000 Nov; 217(2):466-70. PubMed ID: 11058647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of histologic diagnosis between stereotactic core needle biopsy and open surgical biopsy.
    Bauer RL; Sung J; Eckhert KH; Koul A; Castillo NB; Nemoto T
    Ann Surg Oncol; 1997 Jun; 4(4):316-20. PubMed ID: 9181231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follow-up of breast lesions diagnosed as benign with stereotactic core-needle biopsy: frequency of mammographic change and false-negative rate.
    Lee CH; Philpotts LE; Horvath LJ; Tocino I
    Radiology; 1999 Jul; 212(1):189-94. PubMed ID: 10405741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical biopsy findings in patients with atypical hyperplasia diagnosed by stereotaxic core needle biopsy.
    Tocino I; Garcia BM; Carter D
    Ann Surg Oncol; 1996 Sep; 3(5):483-8. PubMed ID: 8876891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of stereotactic biopsy in assessment of nonpalpable breast lesions.
    Wallace JE; Sayler C; McDowell NG; Moseley HS
    Am J Surg; 1996 May; 171(5):471-3. PubMed ID: 8651387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Stereotactic core needle biopsy for diagnosis of mammographic minimal lesions].
    Ge LY; Huan Q; Liu XJ
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2006 Sep; 35(5):551-4. PubMed ID: 17063551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of stereotactic core needle biopsy on pathologic measurement of tumor size of T1 invasive breast carcinomas presenting as mammographic masses.
    Charles M; Edge SB; Winston JS; Hurd TC; Driscoll DL; Stomper PC
    Cancer; 2003 May; 97(9):2137-41. PubMed ID: 12712464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic core needle breast biopsy is an accurate diagnostic technique to assess nonpalpable mammographic abnormalities.
    Fuhrman G; Cederbom G; Champagne J; Farr G; McKinnon W; Bolton J; Ordoyne WK
    J La State Med Soc; 1996 Apr; 148(4):167-70. PubMed ID: 8935619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect on biopsy technique of the breast imaging reporting and data system (BI-RADS) for nonpalpable mammographic abnormalities.
    Ball CG; Butchart M; MacFarlane JK
    Can J Surg; 2002 Aug; 45(4):259-63. PubMed ID: 12174979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-operative simultaneous stereotactic core biopsy and fine-needle aspiration biopsy in the diagnosis of invasive lobular breast carcinoma.
    Leifland K; Lundquist H; Måre K; Erhardt K; Fernstad R
    Acta Radiol; 2000 Jan; 41(1):57-60. PubMed ID: 10665872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic breast biopsy is accurate, minimally invasive, and cost effective.
    Pettine S; Place R; Babu S; Williard W; Kim D; Carter P
    Am J Surg; 1996 May; 171(5):474-6. PubMed ID: 8651388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.